Olshan Frome Wolosky LLP represented Summit Therapeutics in the offering.
Summit Therapeutics Inc. (NASDAQ: SMMT) executed its rights offering of up to 14,312,977 shares of its common stock, par value $0.01 with an aggregate offering value of up to $75,000,000.
Summit Therapeutics Inc. (NASDAQ: SMMT) is a clinical-stage drug discovery and development company.
Olshan Frome Wolosky LLP represented Summit Therapeutics with a team led by corporate partner Adam Finerman (Picture) with assistance from corporate associates Scott Kilian-Clark and Zachary Freedman and tax partner Mark Limardo.
Law Firms: Olshan Frome Wolosky;
Clients: Summit Therapeutics Plc;